BiotechMashup

For cancer patients, who have an increased risk of developing venous thromboembolism due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood clots, according to a recent study.

(American Society of Hematology) Patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are four to six times more likely to develop venous thromboembolism (VTE), a dangerous, often life-threatening condition, according to study results published today in Blood , the Journal of the American Society of Hematology (ASH).

(American Society of Hematology) The latest advances in the treatment of bleeding and clotting disorders will be presented today at the 52nd Annual Meeting of the American Society of Hematology, focusing on venous thrombeombolism (VTE), a potentially life-threatening disorder in which abnormal blood clots form in the veins and restrict the flow of blood. New studies examine risk-prediction models and cutting-edge treatment options for patients with VTE.

(BMJ-British Medical Journal) A new risk prediction tool can identify patients at high risk of serious blood clots (known as venous thromboembolism) who might need preventative treatment, says a study published online today.

(American Society of Hematology) The American Society of Hematology, the world's largest organization concerned with the causes and treatment of blood disorders, today released the Blood journal app for iPhone and iPad. Blood is the official Journal of the Society and the most cited peer-reviewed publication in the field.

(American Society of Hematology) Older patients with Hodgkin lymphoma (HL) and a history of heart disease face a high risk of hospitalization for cardiac complications after completing treatment, according to research published online today in Blood, the journal of the American Society of Hematology. HL is a form of cancer of arising in the lymph nodes, and approximately 8,500 people were diagnosed with the disease in 2009, according to the American Cancer Society.

(American Society of Hematology) A study published today in Blood, the Journal of the American Society of Hematology, highlights updated results for a potential new strategy for preventing graft-versus-host disease and promoting the patient's immune system recovery after hematopoietic stem cell transplantation.

(American Society of Hematology) Results from a study published in Blood, the journal of the American Society of Hematology, reveal a close relationship between pulmonary arterial hypertension -- exceedingly high blood pressure in the arteries carrying blood from the heart to the lungs -- and abnormalities of the blood-forming cells in the bone marrow.

(American Society of Hematology) For the first time, researchers have successfully injected cultured red blood cells (cRBCs) created from human hematopoietic stem cells (HSCs) into a human donor, according to study results published today in Blood, the Journal of the American Society of Hematology (ASH). As the global need for blood continues to increase while the number of blood donors is decreasing, these study results provide hope that one day patients in need of a blood transfusion might become their own donors.